nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA2—epilepsy syndrome	0.107	0.288	CbGaD
Galantamine—CHRNB2—epilepsy syndrome	0.105	0.282	CbGaD
Galantamine—CHRNA7—epilepsy syndrome	0.0617	0.165	CbGaD
Galantamine—CHRNA4—epilepsy syndrome	0.0493	0.132	CbGaD
Galantamine—CHRFAM7A—Amobarbital—epilepsy syndrome	0.0364	0.113	CbGbCtD
Galantamine—CHRNA4—Amobarbital—epilepsy syndrome	0.0364	0.113	CbGbCtD
Galantamine—CHRNA7—Amobarbital—epilepsy syndrome	0.0364	0.113	CbGbCtD
Galantamine—BCHE—epilepsy syndrome	0.032	0.0858	CbGaD
Galantamine—CHRNA4—Primidone—epilepsy syndrome	0.0303	0.0938	CbGbCtD
Galantamine—CHRNA7—Primidone—epilepsy syndrome	0.0303	0.0938	CbGbCtD
Galantamine—CHRFAM7A—Primidone—epilepsy syndrome	0.0303	0.0938	CbGbCtD
Galantamine—CHRNA7—Phenobarbital—epilepsy syndrome	0.0259	0.0803	CbGbCtD
Galantamine—CHRNA4—Phenobarbital—epilepsy syndrome	0.0259	0.0803	CbGbCtD
Galantamine—CHRFAM7A—Phenobarbital—epilepsy syndrome	0.0259	0.0803	CbGbCtD
Galantamine—CYP2D6—epilepsy syndrome	0.0176	0.0471	CbGaD
Galantamine—CHRNB3—pons—epilepsy syndrome	0.00415	0.0853	CbGeAlD
Galantamine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00368	0.0114	CbGbCtD
Galantamine—CYP3A4—Felbamate—epilepsy syndrome	0.00342	0.0106	CbGbCtD
Galantamine—CYP3A4—Trimethadione—epilepsy syndrome	0.00342	0.0106	CbGbCtD
Galantamine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00321	0.00997	CbGbCtD
Galantamine—CYP2D6—Propofol—epilepsy syndrome	0.00304	0.00942	CbGbCtD
Galantamine—CYP3A4—Clonazepam—epilepsy syndrome	0.00291	0.00901	CbGbCtD
Galantamine—CYP3A4—Clobazam—epilepsy syndrome	0.00279	0.00864	CbGbCtD
Galantamine—CYP3A4—Rufinamide—epilepsy syndrome	0.00237	0.00735	CbGbCtD
Galantamine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00231	0.00716	CbGbCtD
Galantamine—CHRNA10—ear—epilepsy syndrome	0.00228	0.0469	CbGeAlD
Galantamine—CYP3A4—Primidone—epilepsy syndrome	0.00216	0.00669	CbGbCtD
Galantamine—CHRNB3—ganglion—epilepsy syndrome	0.00213	0.0437	CbGeAlD
Galantamine—CYP3A4—Phenytoin—epilepsy syndrome	0.00207	0.00642	CbGbCtD
Galantamine—CYP3A4—Propofol—epilepsy syndrome	0.00193	0.00599	CbGbCtD
Galantamine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00185	0.00573	CbGbCtD
Galantamine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00185	0.00573	CbGbCtD
Galantamine—CYP3A4—Midazolam—epilepsy syndrome	0.00182	0.00565	CbGbCtD
Galantamine—CHRNA6—ganglion—epilepsy syndrome	0.00177	0.0365	CbGeAlD
Galantamine—CYP3A4—Diazepam—epilepsy syndrome	0.00175	0.00543	CbGbCtD
Galantamine—CYP3A4—Zonisamide—epilepsy syndrome	0.00171	0.0053	CbGbCtD
Galantamine—CHRNG—tongue—epilepsy syndrome	0.00166	0.034	CbGeAlD
Galantamine—CHRNB3—hindbrain—epilepsy syndrome	0.00161	0.0331	CbGeAlD
Galantamine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00138	0.00428	CbGbCtD
Galantamine—CYP3A4—Topiramate—epilepsy syndrome	0.00124	0.00386	CbGbCtD
Galantamine—CHRNA4—autonomic nervous system—epilepsy syndrome	0.00115	0.0236	CbGeAlD
Galantamine—CHRNA1—tongue—epilepsy syndrome	0.0011	0.0225	CbGeAlD
Galantamine—CHRNA4—telencephalic ventricle—epilepsy syndrome	0.00102	0.021	CbGeAlD
Galantamine—CHRNB3—brainstem—epilepsy syndrome	0.000924	0.019	CbGeAlD
Galantamine—CHRNB3—forebrain—epilepsy syndrome	0.000892	0.0183	CbGeAlD
Galantamine—CHRNB3—telencephalon—epilepsy syndrome	0.00082	0.0169	CbGeAlD
Galantamine—CHRNA6—brainstem—epilepsy syndrome	0.000771	0.0158	CbGeAlD
Galantamine—CHRNA6—forebrain—epilepsy syndrome	0.000745	0.0153	CbGeAlD
Galantamine—CHRNA6—telencephalon—epilepsy syndrome	0.000685	0.0141	CbGeAlD
Galantamine—CHRNA7—ganglion—epilepsy syndrome	0.000646	0.0133	CbGeAlD
Galantamine—CHRNA4—ganglion—epilepsy syndrome	0.000637	0.0131	CbGeAlD
Galantamine—CHRNB3—midbrain—epilepsy syndrome	0.000589	0.0121	CbGeAlD
Galantamine—CHRNA5—head—epilepsy syndrome	0.000563	0.0116	CbGeAlD
Galantamine—CHRNA5—nervous system—epilepsy syndrome	0.000533	0.011	CbGeAlD
Galantamine—CHRNA5—central nervous system—epilepsy syndrome	0.000513	0.0105	CbGeAlD
Galantamine—CHRNB3—head—epilepsy syndrome	0.000511	0.0105	CbGeAlD
Galantamine—CHRNG—medulla oblongata—epilepsy syndrome	0.000507	0.0104	CbGeAlD
Galantamine—CHRNA6—midbrain—epilepsy syndrome	0.000492	0.0101	CbGeAlD
Galantamine—CHRNB3—nervous system—epilepsy syndrome	0.000484	0.00995	CbGeAlD
Galantamine—CHRNA4—hindbrain—epilepsy syndrome	0.000483	0.00993	CbGeAlD
Galantamine—CHRNB3—central nervous system—epilepsy syndrome	0.000466	0.00958	CbGeAlD
Galantamine—CHRNG—midbrain—epilepsy syndrome	0.000463	0.00952	CbGeAlD
Galantamine—CHRNB3—cerebellum—epilepsy syndrome	0.000456	0.00936	CbGeAlD
Galantamine—CHRNB2—forebrain—epilepsy syndrome	0.000428	0.00879	CbGeAlD
Galantamine—CHRNA6—head—epilepsy syndrome	0.000426	0.00876	CbGeAlD
Galantamine—CHRNA3—forebrain—epilepsy syndrome	0.000415	0.00852	CbGeAlD
Galantamine—CHRNA5—brain—epilepsy syndrome	0.000408	0.00838	CbGeAlD
Galantamine—CHRNA6—nervous system—epilepsy syndrome	0.000404	0.0083	CbGeAlD
Galantamine—CHRNG—head—epilepsy syndrome	0.000402	0.00826	CbGeAlD
Galantamine—CHRNB2—telencephalon—epilepsy syndrome	0.000393	0.00808	CbGeAlD
Galantamine—CHRNA6—central nervous system—epilepsy syndrome	0.000389	0.00799	CbGeAlD
Galantamine—CHRNB4—head—epilepsy syndrome	0.000387	0.00795	CbGeAlD
Galantamine—CHRNA2—forebrain—epilepsy syndrome	0.000386	0.00792	CbGeAlD
Galantamine—CHRNA6—cerebellum—epilepsy syndrome	0.00038	0.00781	CbGeAlD
Galantamine—CHRNB3—brain—epilepsy syndrome	0.00037	0.00761	CbGeAlD
Galantamine—CHRNB4—nervous system—epilepsy syndrome	0.000367	0.00754	CbGeAlD
Galantamine—CHRNB4—central nervous system—epilepsy syndrome	0.000353	0.00726	CbGeAlD
Galantamine—CHRNA10—head—epilepsy syndrome	0.000341	0.007	CbGeAlD
Galantamine—CHRFAM7A—forebrain—epilepsy syndrome	0.000335	0.00689	CbGeAlD
Galantamine—CHRNB2—medulla oblongata—epilepsy syndrome	0.000309	0.00635	CbGeAlD
Galantamine—CHRNA6—brain—epilepsy syndrome	0.000309	0.00635	CbGeAlD
Galantamine—CHRFAM7A—telencephalon—epilepsy syndrome	0.000308	0.00634	CbGeAlD
Galantamine—ACHE—telencephalon—epilepsy syndrome	0.000286	0.00588	CbGeAlD
Galantamine—CHRNB2—midbrain—epilepsy syndrome	0.000282	0.0058	CbGeAlD
Galantamine—CHRNB4—brain—epilepsy syndrome	0.000281	0.00576	CbGeAlD
Galantamine—CHRNA4—brainstem—epilepsy syndrome	0.000277	0.00569	CbGeAlD
Galantamine—CHRNB2—spinal cord—epilepsy syndrome	0.000275	0.00566	CbGeAlD
Galantamine—CHRNA7—forebrain—epilepsy syndrome	0.000271	0.00557	CbGeAlD
Galantamine—CHRNA4—forebrain—epilepsy syndrome	0.000267	0.00549	CbGeAlD
Galantamine—Hydrocodone—OPRD1—epilepsy syndrome	0.000266	0.101	CrCbGaD
Galantamine—CHRNA1—head—epilepsy syndrome	0.000266	0.00547	CbGeAlD
Galantamine—Dihydrocodeine—OPRM1—epilepsy syndrome	0.000266	0.101	CrCbGaD
Galantamine—CHRNB1—medulla oblongata—epilepsy syndrome	0.000259	0.00533	CbGeAlD
Galantamine—CHRNA7—telencephalon—epilepsy syndrome	0.000249	0.00512	CbGeAlD
Galantamine—CHRNA4—telencephalon—epilepsy syndrome	0.000246	0.00505	CbGeAlD
Galantamine—CHRNB2—head—epilepsy syndrome	0.000245	0.00503	CbGeAlD
Galantamine—Oxycodone—OPRD1—epilepsy syndrome	0.000243	0.0923	CrCbGaD
Galantamine—CHRNA3—head—epilepsy syndrome	0.000237	0.00488	CbGeAlD
Galantamine—CHRNB1—midbrain—epilepsy syndrome	0.000237	0.00487	CbGeAlD
Galantamine—CHRNB2—nervous system—epilepsy syndrome	0.000232	0.00477	CbGeAlD
Galantamine—Codeine—OPRD1—epilepsy syndrome	0.000232	0.0881	CrCbGaD
Galantamine—CHRNB1—spinal cord—epilepsy syndrome	0.000231	0.00475	CbGeAlD
Galantamine—CHRNA3—nervous system—epilepsy syndrome	0.000225	0.00463	CbGeAlD
Galantamine—ACHE—medulla oblongata—epilepsy syndrome	0.000225	0.00462	CbGeAlD
Galantamine—CHRNB2—central nervous system—epilepsy syndrome	0.000223	0.00459	CbGeAlD
Galantamine—Ethylmorphine—OPRM1—epilepsy syndrome	0.000223	0.0847	CrCbGaD
Galantamine—CHRNA2—head—epilepsy syndrome	0.000221	0.00454	CbGeAlD
Galantamine—CHRNB2—cerebellum—epilepsy syndrome	0.000218	0.00449	CbGeAlD
Galantamine—CHRNA3—central nervous system—epilepsy syndrome	0.000217	0.00445	CbGeAlD
Galantamine—CHRNA3—cerebellum—epilepsy syndrome	0.000212	0.00435	CbGeAlD
Galantamine—CHRNA2—nervous system—epilepsy syndrome	0.000209	0.0043	CbGeAlD
Galantamine—CHRNB1—head—epilepsy syndrome	0.000205	0.00422	CbGeAlD
Galantamine—ACHE—midbrain—epilepsy syndrome	0.000205	0.00422	CbGeAlD
Galantamine—Hydrocodone—OPRM1—epilepsy syndrome	0.000204	0.0774	CrCbGaD
Galantamine—CHRNA2—central nervous system—epilepsy syndrome	0.000202	0.00414	CbGeAlD
Galantamine—ACHE—spinal cord—epilepsy syndrome	0.0002	0.00412	CbGeAlD
Galantamine—CHRNA2—cerebellum—epilepsy syndrome	0.000197	0.00405	CbGeAlD
Galantamine—CHRNA1—brain—epilepsy syndrome	0.000193	0.00396	CbGeAlD
Galantamine—CHRFAM7A—head—epilepsy syndrome	0.000192	0.00395	CbGeAlD
Galantamine—Morphine—OPRD1—epilepsy syndrome	0.000188	0.0713	CrCbGaD
Galantamine—Oxycodone—OPRM1—epilepsy syndrome	0.000186	0.0707	CrCbGaD
Galantamine—CHRNB1—cerebellum—epilepsy syndrome	0.000183	0.00377	CbGeAlD
Galantamine—CYP2D6—hindbrain—epilepsy syndrome	0.000183	0.00376	CbGeAlD
Galantamine—CHRFAM7A—nervous system—epilepsy syndrome	0.000182	0.00374	CbGeAlD
Galantamine—Codeine—OPRM1—epilepsy syndrome	0.000177	0.0674	CrCbGaD
Galantamine—CHRNB2—brain—epilepsy syndrome	0.000177	0.00365	CbGeAlD
Galantamine—CHRNA4—midbrain—epilepsy syndrome	0.000176	0.00363	CbGeAlD
Galantamine—CHRFAM7A—central nervous system—epilepsy syndrome	0.000175	0.0036	CbGeAlD
Galantamine—CHRNA4—spinal cord—epilepsy syndrome	0.000172	0.00354	CbGeAlD
Galantamine—CHRNA3—brain—epilepsy syndrome	0.000172	0.00354	CbGeAlD
Galantamine—CHRNA2—brain—epilepsy syndrome	0.00016	0.00329	CbGeAlD
Galantamine—ACHE—cerebellum—epilepsy syndrome	0.000159	0.00326	CbGeAlD
Galantamine—BCHE—brainstem—epilepsy syndrome	0.000158	0.00325	CbGeAlD
Galantamine—CHRNA7—head—epilepsy syndrome	0.000155	0.00319	CbGeAlD
Galantamine—CHRNA4—head—epilepsy syndrome	0.000153	0.00314	CbGeAlD
Galantamine—BCHE—forebrain—epilepsy syndrome	0.000153	0.00314	CbGeAlD
Galantamine—CHRNB1—brain—epilepsy syndrome	0.000149	0.00306	CbGeAlD
Galantamine—CHRNA7—nervous system—epilepsy syndrome	0.000147	0.00302	CbGeAlD
Galantamine—CHRNA4—nervous system—epilepsy syndrome	0.000145	0.00298	CbGeAlD
Galantamine—Morphine—OPRM1—epilepsy syndrome	0.000144	0.0546	CrCbGaD
Galantamine—CHRNA7—central nervous system—epilepsy syndrome	0.000142	0.00291	CbGeAlD
Galantamine—BCHE—telencephalon—epilepsy syndrome	0.000141	0.00289	CbGeAlD
Galantamine—CHRNA4—central nervous system—epilepsy syndrome	0.00014	0.00287	CbGeAlD
Galantamine—CHRFAM7A—brain—epilepsy syndrome	0.000139	0.00286	CbGeAlD
Galantamine—CHRNA4—cerebellum—epilepsy syndrome	0.000137	0.0028	CbGeAlD
Galantamine—ACHE—brain—epilepsy syndrome	0.000129	0.00265	CbGeAlD
Galantamine—CHRNA7—brain—epilepsy syndrome	0.000112	0.00231	CbGeAlD
Galantamine—CHRNA4—brain—epilepsy syndrome	0.000111	0.00228	CbGeAlD
Galantamine—BCHE—medulla oblongata—epilepsy syndrome	0.00011	0.00227	CbGeAlD
Galantamine—CYP2D6—brainstem—epilepsy syndrome	0.000105	0.00216	CbGeAlD
Galantamine—Dihydrocodeine—CYP2D6—epilepsy syndrome	0.000103	0.0391	CrCbGaD
Galantamine—CYP2D6—forebrain—epilepsy syndrome	0.000101	0.00208	CbGeAlD
Galantamine—BCHE—midbrain—epilepsy syndrome	0.000101	0.00207	CbGeAlD
Galantamine—BCHE—spinal cord—epilepsy syndrome	9.85e-05	0.00202	CbGeAlD
Galantamine—CYP2D6—telencephalon—epilepsy syndrome	9.31e-05	0.00191	CbGeAlD
Galantamine—BCHE—head—epilepsy syndrome	8.75e-05	0.0018	CbGeAlD
Galantamine—Ethylmorphine—CYP2D6—epilepsy syndrome	8.63e-05	0.0328	CrCbGaD
Galantamine—BCHE—nervous system—epilepsy syndrome	8.3e-05	0.00171	CbGeAlD
Galantamine—BCHE—central nervous system—epilepsy syndrome	7.99e-05	0.00164	CbGeAlD
Galantamine—Hydrocodone—CYP2D6—epilepsy syndrome	7.89e-05	0.03	CrCbGaD
Galantamine—BCHE—cerebellum—epilepsy syndrome	7.81e-05	0.0016	CbGeAlD
Galantamine—Oxycodone—CYP2D6—epilepsy syndrome	7.2e-05	0.0274	CrCbGaD
Galantamine—Codeine—CYP2D6—epilepsy syndrome	6.87e-05	0.0261	CrCbGaD
Galantamine—BCHE—brain—epilepsy syndrome	6.34e-05	0.0013	CbGeAlD
Galantamine—CYP2D6—head—epilepsy syndrome	5.8e-05	0.00119	CbGeAlD
Galantamine—CYP3A4—nervous system—epilepsy syndrome	5.59e-05	0.00115	CbGeAlD
Galantamine—Morphine—CYP2D6—epilepsy syndrome	5.56e-05	0.0211	CrCbGaD
Galantamine—CYP2D6—nervous system—epilepsy syndrome	5.5e-05	0.00113	CbGeAlD
Galantamine—CYP3A4—central nervous system—epilepsy syndrome	5.38e-05	0.00111	CbGeAlD
Galantamine—CYP2D6—central nervous system—epilepsy syndrome	5.29e-05	0.00109	CbGeAlD
Galantamine—CYP2D6—cerebellum—epilepsy syndrome	5.17e-05	0.00106	CbGeAlD
Galantamine—CYP2D6—brain—epilepsy syndrome	4.2e-05	0.000863	CbGeAlD
Galantamine—Morphine—ABCB1—epilepsy syndrome	3.97e-05	0.0151	CrCbGaD
Galantamine—Vomiting—Vigabatrin—epilepsy syndrome	2.65e-05	0.000202	CcSEcCtD
Galantamine—Skin disorder—Valproic Acid—epilepsy syndrome	2.65e-05	0.000202	CcSEcCtD
Galantamine—Urinary tract disorder—Topiramate—epilepsy syndrome	2.64e-05	0.000202	CcSEcCtD
Galantamine—Oedema peripheral—Topiramate—epilepsy syndrome	2.64e-05	0.000201	CcSEcCtD
Galantamine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.63e-05	0.000201	CcSEcCtD
Galantamine—Cough—Pregabalin—epilepsy syndrome	2.63e-05	0.000201	CcSEcCtD
Galantamine—Connective tissue disorder—Topiramate—epilepsy syndrome	2.63e-05	0.000201	CcSEcCtD
Galantamine—Nausea—Levetiracetam—epilepsy syndrome	2.63e-05	0.000201	CcSEcCtD
Galantamine—Rash—Vigabatrin—epilepsy syndrome	2.62e-05	0.000201	CcSEcCtD
Galantamine—Dizziness—Felbamate—epilepsy syndrome	2.62e-05	0.000201	CcSEcCtD
Galantamine—Dermatitis—Vigabatrin—epilepsy syndrome	2.62e-05	0.0002	CcSEcCtD
Galantamine—Urethral disorder—Topiramate—epilepsy syndrome	2.62e-05	0.0002	CcSEcCtD
Galantamine—Convulsion—Pregabalin—epilepsy syndrome	2.62e-05	0.0002	CcSEcCtD
Galantamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.61e-05	0.0002	CcSEcCtD
Galantamine—Vision blurred—Gabapentin—epilepsy syndrome	2.61e-05	0.000199	CcSEcCtD
Galantamine—Headache—Vigabatrin—epilepsy syndrome	2.61e-05	0.000199	CcSEcCtD
Galantamine—Hypertension—Pregabalin—epilepsy syndrome	2.61e-05	0.000199	CcSEcCtD
Galantamine—Vomiting—Diazepam—epilepsy syndrome	2.61e-05	0.000199	CcSEcCtD
Galantamine—Anorexia—Valproic Acid—epilepsy syndrome	2.6e-05	0.000199	CcSEcCtD
Galantamine—Tremor—Gabapentin—epilepsy syndrome	2.59e-05	0.000198	CcSEcCtD
Galantamine—Rash—Diazepam—epilepsy syndrome	2.58e-05	0.000198	CcSEcCtD
Galantamine—Dermatitis—Diazepam—epilepsy syndrome	2.58e-05	0.000197	CcSEcCtD
Galantamine—Visual impairment—Topiramate—epilepsy syndrome	2.58e-05	0.000197	CcSEcCtD
Galantamine—Chest pain—Pregabalin—epilepsy syndrome	2.57e-05	0.000196	CcSEcCtD
Galantamine—Arthralgia—Pregabalin—epilepsy syndrome	2.57e-05	0.000196	CcSEcCtD
Galantamine—Myalgia—Pregabalin—epilepsy syndrome	2.57e-05	0.000196	CcSEcCtD
Galantamine—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.57e-05	0.000196	CcSEcCtD
Galantamine—Dizziness—Zonisamide—epilepsy syndrome	2.57e-05	0.000196	CcSEcCtD
Galantamine—Headache—Diazepam—epilepsy syndrome	2.57e-05	0.000196	CcSEcCtD
Galantamine—Anxiety—Pregabalin—epilepsy syndrome	2.56e-05	0.000196	CcSEcCtD
Galantamine—Diarrhoea—Clonazepam—epilepsy syndrome	2.56e-05	0.000196	CcSEcCtD
Galantamine—Anaemia—Gabapentin—epilepsy syndrome	2.56e-05	0.000196	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.55e-05	0.000195	CcSEcCtD
Galantamine—Hypotension—Valproic Acid—epilepsy syndrome	2.55e-05	0.000195	CcSEcCtD
Galantamine—Asthenia—Carbamazepine—epilepsy syndrome	2.55e-05	0.000195	CcSEcCtD
Galantamine—Agitation—Gabapentin—epilepsy syndrome	2.54e-05	0.000194	CcSEcCtD
Galantamine—Diarrhoea—Phenytoin—epilepsy syndrome	2.54e-05	0.000194	CcSEcCtD
Galantamine—Discomfort—Pregabalin—epilepsy syndrome	2.54e-05	0.000194	CcSEcCtD
Galantamine—Nausea—Fosphenytoin—epilepsy syndrome	2.54e-05	0.000194	CcSEcCtD
Galantamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.53e-05	0.000193	CcSEcCtD
Galantamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.53e-05	0.000193	CcSEcCtD
Galantamine—Vomiting—Felbamate—epilepsy syndrome	2.52e-05	0.000193	CcSEcCtD
Galantamine—Dry mouth—Pregabalin—epilepsy syndrome	2.51e-05	0.000192	CcSEcCtD
Galantamine—Rash—Felbamate—epilepsy syndrome	2.5e-05	0.000191	CcSEcCtD
Galantamine—Eye disorder—Topiramate—epilepsy syndrome	2.5e-05	0.000191	CcSEcCtD
Galantamine—Dermatitis—Felbamate—epilepsy syndrome	2.5e-05	0.000191	CcSEcCtD
Galantamine—Malaise—Gabapentin—epilepsy syndrome	2.5e-05	0.000191	CcSEcCtD
Galantamine—Tinnitus—Topiramate—epilepsy syndrome	2.49e-05	0.000191	CcSEcCtD
Galantamine—Vertigo—Gabapentin—epilepsy syndrome	2.49e-05	0.00019	CcSEcCtD
Galantamine—Headache—Felbamate—epilepsy syndrome	2.49e-05	0.00019	CcSEcCtD
Galantamine—Confusional state—Pregabalin—epilepsy syndrome	2.48e-05	0.00019	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.48e-05	0.00019	CcSEcCtD
Galantamine—Cardiac disorder—Topiramate—epilepsy syndrome	2.48e-05	0.00019	CcSEcCtD
Galantamine—Flushing—Topiramate—epilepsy syndrome	2.48e-05	0.00019	CcSEcCtD
Galantamine—Syncope—Gabapentin—epilepsy syndrome	2.48e-05	0.00019	CcSEcCtD
Galantamine—Dizziness—Clonazepam—epilepsy syndrome	2.47e-05	0.000189	CcSEcCtD
Galantamine—Nausea—Vigabatrin—epilepsy syndrome	2.47e-05	0.000189	CcSEcCtD
Galantamine—Vomiting—Zonisamide—epilepsy syndrome	2.47e-05	0.000189	CcSEcCtD
Galantamine—Insomnia—Valproic Acid—epilepsy syndrome	2.46e-05	0.000188	CcSEcCtD
Galantamine—Asthenia—Lamotrigine—epilepsy syndrome	2.46e-05	0.000188	CcSEcCtD
Galantamine—Dizziness—Phenytoin—epilepsy syndrome	2.46e-05	0.000188	CcSEcCtD
Galantamine—Rash—Zonisamide—epilepsy syndrome	2.45e-05	0.000187	CcSEcCtD
Galantamine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.45e-05	0.000187	CcSEcCtD
Galantamine—Palpitations—Gabapentin—epilepsy syndrome	2.45e-05	0.000187	CcSEcCtD
Galantamine—Dermatitis—Zonisamide—epilepsy syndrome	2.45e-05	0.000187	CcSEcCtD
Galantamine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.45e-05	0.000187	CcSEcCtD
Galantamine—Nausea—Diazepam—epilepsy syndrome	2.43e-05	0.000186	CcSEcCtD
Galantamine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.43e-05	0.000186	CcSEcCtD
Galantamine—Headache—Zonisamide—epilepsy syndrome	2.43e-05	0.000186	CcSEcCtD
Galantamine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.43e-05	0.000186	CcSEcCtD
Galantamine—Angiopathy—Topiramate—epilepsy syndrome	2.43e-05	0.000186	CcSEcCtD
Galantamine—Shock—Pregabalin—epilepsy syndrome	2.42e-05	0.000185	CcSEcCtD
Galantamine—Somnolence—Valproic Acid—epilepsy syndrome	2.42e-05	0.000185	CcSEcCtD
Galantamine—Immune system disorder—Topiramate—epilepsy syndrome	2.42e-05	0.000185	CcSEcCtD
Galantamine—Nervous system disorder—Pregabalin—epilepsy syndrome	2.42e-05	0.000185	CcSEcCtD
Galantamine—Cough—Gabapentin—epilepsy syndrome	2.42e-05	0.000185	CcSEcCtD
Galantamine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.41e-05	0.000184	CcSEcCtD
Galantamine—Tachycardia—Pregabalin—epilepsy syndrome	2.4e-05	0.000184	CcSEcCtD
Galantamine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.4e-05	0.000183	CcSEcCtD
Galantamine—Convulsion—Gabapentin—epilepsy syndrome	2.4e-05	0.000183	CcSEcCtD
Galantamine—Skin disorder—Pregabalin—epilepsy syndrome	2.39e-05	0.000183	CcSEcCtD
Galantamine—Hypertension—Gabapentin—epilepsy syndrome	2.39e-05	0.000183	CcSEcCtD
Galantamine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.38e-05	0.000182	CcSEcCtD
Galantamine—Vomiting—Clonazepam—epilepsy syndrome	2.38e-05	0.000182	CcSEcCtD
Galantamine—Decreased appetite—Valproic Acid—epilepsy syndrome	2.37e-05	0.000181	CcSEcCtD
Galantamine—Vomiting—Phenytoin—epilepsy syndrome	2.36e-05	0.000181	CcSEcCtD
Galantamine—Rash—Clonazepam—epilepsy syndrome	2.36e-05	0.00018	CcSEcCtD
Galantamine—Dermatitis—Clonazepam—epilepsy syndrome	2.36e-05	0.00018	CcSEcCtD
Galantamine—Chest pain—Gabapentin—epilepsy syndrome	2.36e-05	0.00018	CcSEcCtD
Galantamine—Arthralgia—Gabapentin—epilepsy syndrome	2.36e-05	0.00018	CcSEcCtD
Galantamine—Myalgia—Gabapentin—epilepsy syndrome	2.36e-05	0.00018	CcSEcCtD
Galantamine—Nausea—Felbamate—epilepsy syndrome	2.36e-05	0.00018	CcSEcCtD
Galantamine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.35e-05	0.00018	CcSEcCtD
Galantamine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.35e-05	0.00018	CcSEcCtD
Galantamine—Fatigue—Valproic Acid—epilepsy syndrome	2.35e-05	0.00018	CcSEcCtD
Galantamine—Anxiety—Gabapentin—epilepsy syndrome	2.35e-05	0.00018	CcSEcCtD
Galantamine—Anorexia—Pregabalin—epilepsy syndrome	2.35e-05	0.00018	CcSEcCtD
Galantamine—Dizziness—Carbamazepine—epilepsy syndrome	2.35e-05	0.000179	CcSEcCtD
Galantamine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.35e-05	0.000179	CcSEcCtD
Galantamine—Headache—Clonazepam—epilepsy syndrome	2.34e-05	0.000179	CcSEcCtD
Galantamine—Rash—Phenytoin—epilepsy syndrome	2.34e-05	0.000179	CcSEcCtD
Galantamine—Mental disorder—Topiramate—epilepsy syndrome	2.34e-05	0.000179	CcSEcCtD
Galantamine—Dermatitis—Phenytoin—epilepsy syndrome	2.34e-05	0.000179	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.34e-05	0.000179	CcSEcCtD
Galantamine—Rash—Oxcarbazepine—epilepsy syndrome	2.33e-05	0.000178	CcSEcCtD
Galantamine—Constipation—Valproic Acid—epilepsy syndrome	2.33e-05	0.000178	CcSEcCtD
Galantamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.33e-05	0.000178	CcSEcCtD
Galantamine—Headache—Phenytoin—epilepsy syndrome	2.33e-05	0.000178	CcSEcCtD
Galantamine—Malnutrition—Topiramate—epilepsy syndrome	2.33e-05	0.000178	CcSEcCtD
Galantamine—Discomfort—Gabapentin—epilepsy syndrome	2.33e-05	0.000178	CcSEcCtD
Galantamine—Headache—Oxcarbazepine—epilepsy syndrome	2.32e-05	0.000177	CcSEcCtD
Galantamine—Nausea—Zonisamide—epilepsy syndrome	2.31e-05	0.000176	CcSEcCtD
Galantamine—Dry mouth—Gabapentin—epilepsy syndrome	2.3e-05	0.000176	CcSEcCtD
Galantamine—Hypotension—Pregabalin—epilepsy syndrome	2.3e-05	0.000176	CcSEcCtD
Galantamine—Flatulence—Topiramate—epilepsy syndrome	2.29e-05	0.000175	CcSEcCtD
Galantamine—Tension—Topiramate—epilepsy syndrome	2.29e-05	0.000175	CcSEcCtD
Galantamine—Dysgeusia—Topiramate—epilepsy syndrome	2.28e-05	0.000174	CcSEcCtD
Galantamine—Confusional state—Gabapentin—epilepsy syndrome	2.28e-05	0.000174	CcSEcCtD
Galantamine—Dizziness—Lamotrigine—epilepsy syndrome	2.27e-05	0.000173	CcSEcCtD
Galantamine—Nervousness—Topiramate—epilepsy syndrome	2.26e-05	0.000173	CcSEcCtD
Galantamine—Vomiting—Carbamazepine—epilepsy syndrome	2.26e-05	0.000172	CcSEcCtD
Galantamine—Back pain—Topiramate—epilepsy syndrome	2.25e-05	0.000172	CcSEcCtD
Galantamine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.25e-05	0.000172	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.24e-05	0.000172	CcSEcCtD
Galantamine—Muscle spasms—Topiramate—epilepsy syndrome	2.24e-05	0.000171	CcSEcCtD
Galantamine—Rash—Carbamazepine—epilepsy syndrome	2.24e-05	0.000171	CcSEcCtD
Galantamine—Dermatitis—Carbamazepine—epilepsy syndrome	2.24e-05	0.000171	CcSEcCtD
Galantamine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.23e-05	0.00017	CcSEcCtD
Galantamine—Insomnia—Pregabalin—epilepsy syndrome	2.23e-05	0.00017	CcSEcCtD
Galantamine—Nausea—Clonazepam—epilepsy syndrome	2.22e-05	0.00017	CcSEcCtD
Galantamine—Headache—Carbamazepine—epilepsy syndrome	2.22e-05	0.00017	CcSEcCtD
Galantamine—Shock—Gabapentin—epilepsy syndrome	2.22e-05	0.00017	CcSEcCtD
Galantamine—Nervous system disorder—Gabapentin—epilepsy syndrome	2.22e-05	0.000169	CcSEcCtD
Galantamine—Paraesthesia—Pregabalin—epilepsy syndrome	2.21e-05	0.000169	CcSEcCtD
Galantamine—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.21e-05	0.000169	CcSEcCtD
Galantamine—Nausea—Phenytoin—epilepsy syndrome	2.21e-05	0.000169	CcSEcCtD
Galantamine—Tachycardia—Gabapentin—epilepsy syndrome	2.2e-05	0.000169	CcSEcCtD
Galantamine—Nausea—Oxcarbazepine—epilepsy syndrome	2.2e-05	0.000168	CcSEcCtD
Galantamine—Vision blurred—Topiramate—epilepsy syndrome	2.19e-05	0.000168	CcSEcCtD
Galantamine—Skin disorder—Gabapentin—epilepsy syndrome	2.19e-05	0.000168	CcSEcCtD
Galantamine—Somnolence—Pregabalin—epilepsy syndrome	2.19e-05	0.000167	CcSEcCtD
Galantamine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.18e-05	0.000167	CcSEcCtD
Galantamine—Tremor—Topiramate—epilepsy syndrome	2.18e-05	0.000167	CcSEcCtD
Galantamine—Vomiting—Lamotrigine—epilepsy syndrome	2.18e-05	0.000167	CcSEcCtD
Galantamine—Rash—Lamotrigine—epilepsy syndrome	2.16e-05	0.000165	CcSEcCtD
Galantamine—Ill-defined disorder—Topiramate—epilepsy syndrome	2.16e-05	0.000165	CcSEcCtD
Galantamine—Dermatitis—Lamotrigine—epilepsy syndrome	2.16e-05	0.000165	CcSEcCtD
Galantamine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.15e-05	0.000165	CcSEcCtD
Galantamine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.15e-05	0.000165	CcSEcCtD
Galantamine—Anorexia—Gabapentin—epilepsy syndrome	2.15e-05	0.000165	CcSEcCtD
Galantamine—Anaemia—Topiramate—epilepsy syndrome	2.15e-05	0.000165	CcSEcCtD
Galantamine—Headache—Lamotrigine—epilepsy syndrome	2.15e-05	0.000164	CcSEcCtD
Galantamine—Decreased appetite—Pregabalin—epilepsy syndrome	2.14e-05	0.000164	CcSEcCtD
Galantamine—Agitation—Topiramate—epilepsy syndrome	2.14e-05	0.000164	CcSEcCtD
Galantamine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.13e-05	0.000163	CcSEcCtD
Galantamine—Fatigue—Pregabalin—epilepsy syndrome	2.12e-05	0.000162	CcSEcCtD
Galantamine—Hypotension—Gabapentin—epilepsy syndrome	2.11e-05	0.000161	CcSEcCtD
Galantamine—Nausea—Carbamazepine—epilepsy syndrome	2.11e-05	0.000161	CcSEcCtD
Galantamine—Constipation—Pregabalin—epilepsy syndrome	2.11e-05	0.000161	CcSEcCtD
Galantamine—Malaise—Topiramate—epilepsy syndrome	2.1e-05	0.000161	CcSEcCtD
Galantamine—Vertigo—Topiramate—epilepsy syndrome	2.09e-05	0.00016	CcSEcCtD
Galantamine—Syncope—Topiramate—epilepsy syndrome	2.09e-05	0.00016	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.06e-05	0.000157	CcSEcCtD
Galantamine—Palpitations—Topiramate—epilepsy syndrome	2.06e-05	0.000157	CcSEcCtD
Galantamine—Loss of consciousness—Topiramate—epilepsy syndrome	2.05e-05	0.000156	CcSEcCtD
Galantamine—Insomnia—Gabapentin—epilepsy syndrome	2.04e-05	0.000156	CcSEcCtD
Galantamine—Nausea—Lamotrigine—epilepsy syndrome	2.04e-05	0.000156	CcSEcCtD
Galantamine—Cough—Topiramate—epilepsy syndrome	2.03e-05	0.000155	CcSEcCtD
Galantamine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.03e-05	0.000155	CcSEcCtD
Galantamine—Paraesthesia—Gabapentin—epilepsy syndrome	2.03e-05	0.000155	CcSEcCtD
Galantamine—Convulsion—Topiramate—epilepsy syndrome	2.02e-05	0.000154	CcSEcCtD
Galantamine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.01e-05	0.000154	CcSEcCtD
Galantamine—Hypertension—Topiramate—epilepsy syndrome	2.01e-05	0.000154	CcSEcCtD
Galantamine—Somnolence—Gabapentin—epilepsy syndrome	2.01e-05	0.000154	CcSEcCtD
Galantamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.01e-05	0.000153	CcSEcCtD
Galantamine—Dyspepsia—Gabapentin—epilepsy syndrome	1.99e-05	0.000152	CcSEcCtD
Galantamine—Chest pain—Topiramate—epilepsy syndrome	1.98e-05	0.000152	CcSEcCtD
Galantamine—Myalgia—Topiramate—epilepsy syndrome	1.98e-05	0.000152	CcSEcCtD
Galantamine—Arthralgia—Topiramate—epilepsy syndrome	1.98e-05	0.000152	CcSEcCtD
Galantamine—Anxiety—Topiramate—epilepsy syndrome	1.98e-05	0.000151	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.97e-05	0.000151	CcSEcCtD
Galantamine—Decreased appetite—Gabapentin—epilepsy syndrome	1.96e-05	0.00015	CcSEcCtD
Galantamine—Discomfort—Topiramate—epilepsy syndrome	1.96e-05	0.00015	CcSEcCtD
Galantamine—Asthenia—Valproic Acid—epilepsy syndrome	1.96e-05	0.000149	CcSEcCtD
Galantamine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.95e-05	0.000149	CcSEcCtD
Galantamine—Fatigue—Gabapentin—epilepsy syndrome	1.95e-05	0.000149	CcSEcCtD
Galantamine—Body temperature increased—Pregabalin—epilepsy syndrome	1.95e-05	0.000149	CcSEcCtD
Galantamine—Abdominal pain—Pregabalin—epilepsy syndrome	1.95e-05	0.000149	CcSEcCtD
Galantamine—Dry mouth—Topiramate—epilepsy syndrome	1.94e-05	0.000148	CcSEcCtD
Galantamine—Constipation—Gabapentin—epilepsy syndrome	1.93e-05	0.000148	CcSEcCtD
Galantamine—Confusional state—Topiramate—epilepsy syndrome	1.92e-05	0.000146	CcSEcCtD
Galantamine—Shock—Topiramate—epilepsy syndrome	1.87e-05	0.000143	CcSEcCtD
Galantamine—Diarrhoea—Valproic Acid—epilepsy syndrome	1.86e-05	0.000143	CcSEcCtD
Galantamine—Nervous system disorder—Topiramate—epilepsy syndrome	1.86e-05	0.000142	CcSEcCtD
Galantamine—Feeling abnormal—Gabapentin—epilepsy syndrome	1.86e-05	0.000142	CcSEcCtD
Galantamine—Thrombocytopenia—Topiramate—epilepsy syndrome	1.86e-05	0.000142	CcSEcCtD
Galantamine—Tachycardia—Topiramate—epilepsy syndrome	1.85e-05	0.000142	CcSEcCtD
Galantamine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.85e-05	0.000141	CcSEcCtD
Galantamine—Skin disorder—Topiramate—epilepsy syndrome	1.85e-05	0.000141	CcSEcCtD
Galantamine—Hyperhidrosis—Topiramate—epilepsy syndrome	1.84e-05	0.00014	CcSEcCtD
Galantamine—Hypersensitivity—Pregabalin—epilepsy syndrome	1.81e-05	0.000139	CcSEcCtD
Galantamine—Anorexia—Topiramate—epilepsy syndrome	1.81e-05	0.000138	CcSEcCtD
Galantamine—Dizziness—Valproic Acid—epilepsy syndrome	1.8e-05	0.000138	CcSEcCtD
Galantamine—Body temperature increased—Gabapentin—epilepsy syndrome	1.79e-05	0.000137	CcSEcCtD
Galantamine—Abdominal pain—Gabapentin—epilepsy syndrome	1.79e-05	0.000137	CcSEcCtD
Galantamine—Hypotension—Topiramate—epilepsy syndrome	1.78e-05	0.000136	CcSEcCtD
Galantamine—Asthenia—Pregabalin—epilepsy syndrome	1.77e-05	0.000135	CcSEcCtD
Galantamine—Vomiting—Valproic Acid—epilepsy syndrome	1.73e-05	0.000132	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.73e-05	0.000132	CcSEcCtD
Galantamine—Insomnia—Topiramate—epilepsy syndrome	1.72e-05	0.000131	CcSEcCtD
Galantamine—Rash—Valproic Acid—epilepsy syndrome	1.72e-05	0.000131	CcSEcCtD
Galantamine—Dermatitis—Valproic Acid—epilepsy syndrome	1.72e-05	0.000131	CcSEcCtD
Galantamine—Headache—Valproic Acid—epilepsy syndrome	1.71e-05	0.000131	CcSEcCtD
Galantamine—Paraesthesia—Topiramate—epilepsy syndrome	1.71e-05	0.00013	CcSEcCtD
Galantamine—Somnolence—Topiramate—epilepsy syndrome	1.69e-05	0.000129	CcSEcCtD
Galantamine—Diarrhoea—Pregabalin—epilepsy syndrome	1.69e-05	0.000129	CcSEcCtD
Galantamine—Dyspepsia—Topiramate—epilepsy syndrome	1.67e-05	0.000128	CcSEcCtD
Galantamine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.66e-05	0.000127	CcSEcCtD
Galantamine—Decreased appetite—Topiramate—epilepsy syndrome	1.65e-05	0.000126	CcSEcCtD
Galantamine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.64e-05	0.000125	CcSEcCtD
Galantamine—Fatigue—Topiramate—epilepsy syndrome	1.64e-05	0.000125	CcSEcCtD
Galantamine—Dizziness—Pregabalin—epilepsy syndrome	1.63e-05	0.000125	CcSEcCtD
Galantamine—Constipation—Topiramate—epilepsy syndrome	1.63e-05	0.000124	CcSEcCtD
Galantamine—Asthenia—Gabapentin—epilepsy syndrome	1.62e-05	0.000124	CcSEcCtD
Galantamine—Nausea—Valproic Acid—epilepsy syndrome	1.62e-05	0.000124	CcSEcCtD
Galantamine—Vomiting—Pregabalin—epilepsy syndrome	1.57e-05	0.00012	CcSEcCtD
Galantamine—Feeling abnormal—Topiramate—epilepsy syndrome	1.57e-05	0.00012	CcSEcCtD
Galantamine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.55e-05	0.000119	CcSEcCtD
Galantamine—Rash—Pregabalin—epilepsy syndrome	1.55e-05	0.000119	CcSEcCtD
Galantamine—Dermatitis—Pregabalin—epilepsy syndrome	1.55e-05	0.000119	CcSEcCtD
Galantamine—Diarrhoea—Gabapentin—epilepsy syndrome	1.55e-05	0.000118	CcSEcCtD
Galantamine—Headache—Pregabalin—epilepsy syndrome	1.54e-05	0.000118	CcSEcCtD
Galantamine—Abdominal pain—Topiramate—epilepsy syndrome	1.5e-05	0.000115	CcSEcCtD
Galantamine—Body temperature increased—Topiramate—epilepsy syndrome	1.5e-05	0.000115	CcSEcCtD
Galantamine—Dizziness—Gabapentin—epilepsy syndrome	1.49e-05	0.000114	CcSEcCtD
Galantamine—Nausea—Pregabalin—epilepsy syndrome	1.46e-05	0.000112	CcSEcCtD
Galantamine—Vomiting—Gabapentin—epilepsy syndrome	1.44e-05	0.00011	CcSEcCtD
Galantamine—Rash—Gabapentin—epilepsy syndrome	1.42e-05	0.000109	CcSEcCtD
Galantamine—Dermatitis—Gabapentin—epilepsy syndrome	1.42e-05	0.000109	CcSEcCtD
Galantamine—Headache—Gabapentin—epilepsy syndrome	1.42e-05	0.000108	CcSEcCtD
Galantamine—Hypersensitivity—Topiramate—epilepsy syndrome	1.4e-05	0.000107	CcSEcCtD
Galantamine—Asthenia—Topiramate—epilepsy syndrome	1.36e-05	0.000104	CcSEcCtD
Galantamine—Nausea—Gabapentin—epilepsy syndrome	1.34e-05	0.000103	CcSEcCtD
Galantamine—Diarrhoea—Topiramate—epilepsy syndrome	1.3e-05	9.94e-05	CcSEcCtD
Galantamine—Dizziness—Topiramate—epilepsy syndrome	1.26e-05	9.61e-05	CcSEcCtD
Galantamine—Vomiting—Topiramate—epilepsy syndrome	1.21e-05	9.24e-05	CcSEcCtD
Galantamine—Rash—Topiramate—epilepsy syndrome	1.2e-05	9.16e-05	CcSEcCtD
Galantamine—Dermatitis—Topiramate—epilepsy syndrome	1.2e-05	9.15e-05	CcSEcCtD
Galantamine—Headache—Topiramate—epilepsy syndrome	1.19e-05	9.1e-05	CcSEcCtD
Galantamine—Nausea—Topiramate—epilepsy syndrome	1.13e-05	8.63e-05	CcSEcCtD
Galantamine—BCHE—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	3.46e-06	2.84e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—COX3—epilepsy syndrome	3.36e-06	2.75e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ATIC—epilepsy syndrome	3.26e-06	2.67e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—UPB1—epilepsy syndrome	3.26e-06	2.67e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NEU1—epilepsy syndrome	3.26e-06	2.67e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	3.26e-06	2.67e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.25e-06	2.66e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLCO1A2—epilepsy syndrome	3.18e-06	2.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CACNA2D2—epilepsy syndrome	3.18e-06	2.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—KCNB1—epilepsy syndrome	3.18e-06	2.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PFKL—epilepsy syndrome	3.18e-06	2.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC6A8—epilepsy syndrome	3.18e-06	2.61e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HSD17B4—epilepsy syndrome	3.14e-06	2.57e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.11e-06	2.55e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.09e-06	2.53e-05	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.08e-06	2.52e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.08e-06	2.52e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GBE1—epilepsy syndrome	3.03e-06	2.49e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPP1R3C—epilepsy syndrome	3.03e-06	2.49e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—EIF2S1—epilepsy syndrome	3.01e-06	2.47e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACTB—epilepsy syndrome	2.98e-06	2.44e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—PRKCB—epilepsy syndrome	2.98e-06	2.44e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.97e-06	2.43e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	2.93e-06	2.4e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—UPB1—epilepsy syndrome	2.91e-06	2.39e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ATIC—epilepsy syndrome	2.91e-06	2.39e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NEU1—epilepsy syndrome	2.91e-06	2.39e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ASAH1—epilepsy syndrome	2.85e-06	2.34e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HSD17B4—epilepsy syndrome	2.8e-06	2.3e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—STXBP1—epilepsy syndrome	2.78e-06	2.27e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.72e-06	2.23e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GBE1—epilepsy syndrome	2.71e-06	2.22e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPP1R3C—epilepsy syndrome	2.71e-06	2.22e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALAD—epilepsy syndrome	2.7e-06	2.22e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NT5E—epilepsy syndrome	2.7e-06	2.22e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—EIF2S1—epilepsy syndrome	2.69e-06	2.2e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACTB—epilepsy syndrome	2.66e-06	2.18e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—PRKCB—epilepsy syndrome	2.65e-06	2.17e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.64e-06	2.16e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CACNA1A—epilepsy syndrome	2.58e-06	2.11e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALDH7A1—epilepsy syndrome	2.58e-06	2.11e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—BCHE—epilepsy syndrome	2.56e-06	2.1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA13—epilepsy syndrome	2.55e-06	2.09e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ASAH1—epilepsy syndrome	2.55e-06	2.08e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ST3GAL3—epilepsy syndrome	2.53e-06	2.07e-05	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.49e-06	2.04e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—STXBP1—epilepsy syndrome	2.48e-06	2.03e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ADSL—epilepsy syndrome	2.47e-06	2.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.44e-06	2e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GLUL—epilepsy syndrome	2.43e-06	1.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2.42e-06	1.98e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NT5E—epilepsy syndrome	2.41e-06	1.98e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALAD—epilepsy syndrome	2.41e-06	1.98e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.4e-06	1.97e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.39e-06	1.96e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CACNA1D—epilepsy syndrome	2.38e-06	1.95e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.37e-06	1.94e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.31e-06	1.89e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDH7A1—epilepsy syndrome	2.3e-06	1.89e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CACNA1A—epilepsy syndrome	2.3e-06	1.89e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ST3GAL3—epilepsy syndrome	2.25e-06	1.85e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PLAUR—epilepsy syndrome	2.23e-06	1.83e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TXNRD1—epilepsy syndrome	2.23e-06	1.82e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ADSL—epilepsy syndrome	2.21e-06	1.81e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.18e-06	1.79e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GLUL—epilepsy syndrome	2.16e-06	1.77e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AQP1—epilepsy syndrome	2.16e-06	1.77e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.15e-06	1.77e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CACNA1D—epilepsy syndrome	2.12e-06	1.74e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.08e-06	1.7e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.02e-06	1.65e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PLAUR—epilepsy syndrome	1.99e-06	1.63e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TXNRD1—epilepsy syndrome	1.99e-06	1.63e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.98e-06	1.62e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CHRM3—epilepsy syndrome	1.96e-06	1.6e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—KCNJ11—epilepsy syndrome	1.96e-06	1.6e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PDXK—epilepsy syndrome	1.93e-06	1.58e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FAR1—epilepsy syndrome	1.93e-06	1.58e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	1.93e-06	1.58e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CERS1—epilepsy syndrome	1.93e-06	1.58e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADK—epilepsy syndrome	1.93e-06	1.58e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	1.93e-06	1.58e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AQP1—epilepsy syndrome	1.93e-06	1.58e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.85e-06	1.52e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.82e-06	1.49e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.78e-06	1.46e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GAMT—epilepsy syndrome	1.77e-06	1.45e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	1.77e-06	1.45e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	1.77e-06	1.45e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PNPO—epilepsy syndrome	1.77e-06	1.45e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CHRM3—epilepsy syndrome	1.74e-06	1.43e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—KCNJ11—epilepsy syndrome	1.74e-06	1.43e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.67e-06	1.36e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA4—epilepsy syndrome	1.64e-06	1.35e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—QDPR—epilepsy syndrome	1.64e-06	1.35e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	1.64e-06	1.34e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.62e-06	1.33e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCG2—epilepsy syndrome	1.59e-06	1.31e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.59e-06	1.3e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—AGT—epilepsy syndrome	1.57e-06	1.29e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2C19—epilepsy syndrome	1.55e-06	1.27e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—COX3—epilepsy syndrome	1.54e-06	1.26e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP11A1—epilepsy syndrome	1.54e-06	1.26e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.53e-06	1.26e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.47e-06	1.21e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.46e-06	1.2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.46e-06	1.2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.46e-06	1.2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.46e-06	1.2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.46e-06	1.2e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCG2—epilepsy syndrome	1.42e-06	1.16e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—AGT—epilepsy syndrome	1.4e-06	1.15e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.4e-06	1.14e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2D6—epilepsy syndrome	1.39e-06	1.14e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2C19—epilepsy syndrome	1.39e-06	1.14e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP11A1—epilepsy syndrome	1.38e-06	1.13e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.37e-06	1.12e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.34e-06	1.1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.34e-06	1.1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.34e-06	1.1e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ADRA2A—epilepsy syndrome	1.33e-06	1.09e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—POMC—epilepsy syndrome	1.32e-06	1.08e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—BCHE—epilepsy syndrome	1.32e-06	1.08e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CCL2—epilepsy syndrome	1.3e-06	1.06e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.29e-06	1.06e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.26e-06	1.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.26e-06	1.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.26e-06	1.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.26e-06	1.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.26e-06	1.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.26e-06	1.03e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC2A1—epilepsy syndrome	1.26e-06	1.03e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.25e-06	1.02e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLCB1—epilepsy syndrome	1.25e-06	1.02e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.24e-06	1.02e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.24e-06	1.02e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2D6—epilepsy syndrome	1.24e-06	1.02e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TH—epilepsy syndrome	1.24e-06	1.02e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.22e-06	1e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ADRA2A—epilepsy syndrome	1.18e-06	9.69e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	1.18e-06	9.68e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.17e-06	9.59e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	1.16e-06	9.47e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.16e-06	9.46e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.16e-06	9.46e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.16e-06	9.46e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.16e-06	9.46e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.14e-06	9.32e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC2A1—epilepsy syndrome	1.12e-06	9.21e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLCB1—epilepsy syndrome	1.11e-06	9.11e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.11e-06	9.09e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.11e-06	9.09e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TH—epilepsy syndrome	1.11e-06	9.07e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.09e-06	8.93e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.07e-06	8.8e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.07e-06	8.8e-06	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.07e-06	8.77e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.06e-06	8.67e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.06e-06	8.67e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMOX1—epilepsy syndrome	1.04e-06	8.49e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.04e-06	8.48e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAT—epilepsy syndrome	1.02e-06	8.38e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.01e-06	8.31e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.01e-06	8.27e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	9.95e-07	8.15e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCB1—epilepsy syndrome	9.95e-07	8.15e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	9.77e-07	8e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	9.57e-07	7.84e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	9.57e-07	7.84e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	9.57e-07	7.84e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	9.57e-07	7.84e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	9.57e-07	7.84e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GPX1—epilepsy syndrome	9.25e-07	7.58e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMOX1—epilepsy syndrome	9.25e-07	7.57e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	9.14e-07	7.48e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAT—epilepsy syndrome	9.12e-07	7.47e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCB1—epilepsy syndrome	8.88e-07	7.27e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	8.87e-07	7.26e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	8.75e-07	7.17e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	8.75e-07	7.17e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	8.75e-07	7.17e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	8.43e-07	6.9e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GPX1—epilepsy syndrome	8.25e-07	6.76e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	8.14e-07	6.67e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	8.14e-07	6.67e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AGT—epilepsy syndrome	8.11e-07	6.64e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	8.02e-07	6.57e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	8.02e-07	6.57e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOE—epilepsy syndrome	7.95e-07	6.51e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	7.65e-07	6.27e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.44e-07	6.1e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.25e-07	5.94e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.25e-07	5.94e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AGT—epilepsy syndrome	7.23e-07	5.93e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOE—epilepsy syndrome	7.09e-07	5.81e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	6.92e-07	5.67e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	6.92e-07	5.67e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—POMC—epilepsy syndrome	6.83e-07	5.59e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.77e-07	5.55e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	6.63e-07	5.43e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	6.54e-07	5.36e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.51e-07	5.33e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.39e-07	5.23e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	6.37e-07	5.22e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	6.33e-07	5.19e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—epilepsy syndrome	6.22e-07	5.1e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—POMC—epilepsy syndrome	6.09e-07	4.99e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.97e-07	4.89e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.8e-07	4.75e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—epilepsy syndrome	5.55e-07	4.55e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—epilepsy syndrome	5.44e-07	4.46e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	5.44e-07	4.46e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	5.42e-07	4.44e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.24e-07	4.3e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.24e-07	4.3e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	5.17e-07	4.23e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	5.11e-07	4.19e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TH—epilepsy syndrome	5.09e-07	4.17e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—epilepsy syndrome	4.86e-07	3.98e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.27e-07	3.5e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	4.25e-07	3.48e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAT—epilepsy syndrome	4.19e-07	3.44e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.17e-07	3.41e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.14e-07	3.39e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	4.08e-07	3.34e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.79e-07	3.11e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.74e-07	3.06e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.56e-07	2.91e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.54e-07	2.9e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.38e-07	2.77e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.34e-07	2.74e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TH—epilepsy syndrome	3.33e-07	2.73e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AGT—epilepsy syndrome	3.33e-07	2.72e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOE—epilepsy syndrome	3.26e-07	2.67e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.8e-07	2.29e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.78e-07	2.28e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.74e-07	2.25e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—epilepsy syndrome	2.74e-07	2.24e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.67e-07	2.19e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.55e-07	2.09e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.48e-07	2.03e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—epilepsy syndrome	2.44e-07	2e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.23e-07	1.83e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.17e-07	1.78e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.13e-07	1.75e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.83e-07	1.5e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.67e-07	1.37e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.46e-07	1.2e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.12e-07	9.19e-07	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.34e-08	6.01e-07	CbGpPWpGaD
